This technology is aligned with our 3M Infection Prevention goals to partner with hospitals to lessen hospital-acquired infections also to meet the requirements of our clients and the patients they serve. The new agreement with TSO3 contains regional commercialization of the merchandise as regulatory clearance or registration is acquired and we are enthusiastic in order to offer this unique technology globally . SOURCE TSO3 INC.. 3M to provide and distribute TSO3’s STERIZONE 125L+ Sterilizer TSO3 Inc. and 3M today announced that an contract provides been reached for 3M to be the distinctive supplier and distributor of TSO3’s STERIZONE 125L+ Sterilizer. The partnership with TSO3, an innovator in low temp sterilization technology for medical gadgets in healthcare settings through the use of ozone, will include new cycles to attain acute care services through 3M’s global sales channel.For the principal end point, we performed prespecified subgroup analyses regarding to age also, sex, Killip class, period to randomization, place of randomization, infarct area, systolic blood pressure, weight, status regarding a brief history of hypertension or diabetes, Thrombolysis in Myocardial Infarction risk rating, and randomization before or after adoption of the protocol amendment. We evaluated the interactions between subgroups and treatment. An observed case analysis was performed except for analyses in which there is a proportion of missing data of more than 1 percent and for which a multiple imputation evaluation was performed. The imputation model was based on baseline characteristics as well as all one efficacy and basic safety end points.